Blood Plasma Derivatives Market to 2027 - Global Analysis and Forecasts By Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Others); Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrands Disease (vWD), Other Application); End User (Hospitals, Clinics, Other End Users) and Geography
Report Code: TIPRE00007250 No. of Pages: 150 Category: Biotechnology Status: Upcoming
MARKET INTRODUCTION
Product derived from blood plasma on fractionation are called as plasma derivatives. Plasma derivatives are widely used to treat different diseases. Blood plasma helps to maintain pH level of body fluid. It is one of the important blood component in which WBC's and platelets are suspended. It also helps in transporting nutrients throughout the body. Blood plasma contains more than 100 different components such as fibrinogen, albumin, immunoglobulins, clotting factors and protease inhibitors. There are variety of plasma derivatives available in market include albumin, factor VIII & IX, anti-inhibitor coagulation complex (AICC), immunoglobulins, including Rh immune globulin, alpha 1-proteinase inhibitor concentrate, and anti-thrombin III concentrate.
MARKET DYNAMICS
The Blood Plasma Derivatives market is anticipated to grow in the forecast period owing to driving factors such as rising prevalence of diseases such as immunodeficiency diseases, hemophilia, etc., rising awareness towards blood & blood component donation, rising geriatric population, and adoption of blood plasma derivatives products.
MARKET SCOPE
The "Global Blood Plasma Derivatives Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Blood Plasma Derivatives market with detailed market segmentation by type, application, end user, and geography. The global Blood Plasma Derivatives market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Blood Plasma Derivatives market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global Blood Plasma Derivatives market is segmented on the basis of type, application, and end user. Based on type, the market is segmented into Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and others. Based on application, the market is segmented into Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrands Disease (vWD), and other application. Based on end user, the market is segmented into hospitals, clinics, and other end users.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Blood Plasma Derivatives market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Blood Plasma Derivatives market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Blood Plasma Derivatives market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Blood Plasma Derivatives market in these regions.
The reports cover key developments in the Blood Plasma Derivatives market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Blood Plasma Derivatives market are anticipated to lucrative growth opportunities in the future with the rising demand for Blood Plasma Derivatives market in the global market. Below mentioned is the list of few companies engaged in the Blood Plasma Derivatives market.
The report also includes the profiles of key Blood Plasma Derivatives market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Product derived from blood plasma on fractionation are called as plasma derivatives. Plasma derivatives are widely used to treat different diseases. Blood plasma helps to maintain pH level of body fluid. It is one of the important blood component in which WBC's and platelets are suspended. It also helps in transporting nutrients throughout the body. Blood plasma contains more than 100 different components such as fibrinogen, albumin, immunoglobulins, clotting factors and protease inhibitors. There are variety of plasma derivatives available in market include albumin, factor VIII & IX, anti-inhibitor coagulation complex (AICC), immunoglobulins, including Rh immune globulin, alpha 1-proteinase inhibitor concentrate, and anti-thrombin III concentrate.
MARKET DYNAMICS
The Blood Plasma Derivatives market is anticipated to grow in the forecast period owing to driving factors such as rising prevalence of diseases such as immunodeficiency diseases, hemophilia, etc., rising awareness towards blood & blood component donation, rising geriatric population, and adoption of blood plasma derivatives products.
MARKET SCOPE
The "Global Blood Plasma Derivatives Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Blood Plasma Derivatives market with detailed market segmentation by type, application, end user, and geography. The global Blood Plasma Derivatives market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Blood Plasma Derivatives market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global Blood Plasma Derivatives market is segmented on the basis of type, application, and end user. Based on type, the market is segmented into Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and others. Based on application, the market is segmented into Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrands Disease (vWD), and other application. Based on end user, the market is segmented into hospitals, clinics, and other end users.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Blood Plasma Derivatives market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Blood Plasma Derivatives market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Blood Plasma Derivatives market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Blood Plasma Derivatives market in these regions.
The reports cover key developments in the Blood Plasma Derivatives market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Blood Plasma Derivatives market are anticipated to lucrative growth opportunities in the future with the rising demand for Blood Plasma Derivatives market in the global market. Below mentioned is the list of few companies engaged in the Blood Plasma Derivatives market.
The report also includes the profiles of key Blood Plasma Derivatives market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Grifols, S.A.
- SK Plasma Co., Ltd.
- Fusion Health Care Pvt. Ltd.
- Biotest AG
- Green Cross Corporation
- Baxter International Inc.
- LFB S.A.
- Octapharma AG
- CSL Limited
- Shire Plc
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Blood Plasma Derivatives Market - By Type
1.3.2 Blood Plasma Derivatives Market - By Application
1.3.3 Blood Plasma Derivatives Market - By End User
1.3.4 Blood Plasma Derivatives Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BLOOD PLASMA DERIVATIVES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BLOOD PLASMA DERIVATIVES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BLOOD PLASMA DERIVATIVES MARKET - GLOBAL MARKET ANALYSIS
6.1. BLOOD PLASMA DERIVATIVES - GLOBAL MARKET OVERVIEW
6.2. BLOOD PLASMA DERIVATIVES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. BLOOD PLASMA DERIVATIVES MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ALBUMIN
7.3.1. Overview
7.3.2. Albumin Market Forecast and Analysis
7.4. FACTOR VIII
7.4.1. Overview
7.4.2. Factor VIII Market Forecast and Analysis
7.5. FACTOR IX
7.5.1. Overview
7.5.2. Factor IX Market Forecast and Analysis
7.6. IMMUNOGLOBULIN
7.6.1. Overview
7.6.2. Immunoglobulin Market Forecast and Analysis
7.7. HYPERIMMUNE GLOBULIN
7.7.1. Overview
7.7.2. Hyperimmune Globulin Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. BLOOD PLASMA DERIVATIVES MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HEMOPHILIA
8.3.1. Overview
8.3.2. Hemophilia Market Forecast and Analysis
8.4. HYPOGAMMAGLOBULINEMIA
8.4.1. Overview
8.4.2. Hypogammaglobulinemia Market Forecast and Analysis
8.5. IMMUNODEFICIENCY DISEASES
8.5.1. Overview
8.5.2. Immunodeficiency Diseases Market Forecast and Analysis
8.6. VON WILLEBRANDS DISEASE (VWD)
8.6.1. Overview
8.6.2. von Willebrands Disease (vWD) Market Forecast and Analysis
8.7. OTHER APPLICATION
8.7.1. Overview
8.7.2. Other Application Market Forecast and Analysis
9. BLOOD PLASMA DERIVATIVES MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. OTHER END USERS
9.5.1. Overview
9.5.2. Other End Users Market Forecast and Analysis
10. BLOOD PLASMA DERIVATIVES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Blood Plasma Derivatives Market Overview
10.1.2 North America Blood Plasma Derivatives Market Forecasts and Analysis
10.1.3 North America Blood Plasma Derivatives Market Forecasts and Analysis - By Type
10.1.4 North America Blood Plasma Derivatives Market Forecasts and Analysis - By Application
10.1.5 North America Blood Plasma Derivatives Market Forecasts and Analysis - By End User
10.1.6 North America Blood Plasma Derivatives Market Forecasts and Analysis - By Countries
10.1.6.1 United States Blood Plasma Derivatives Market
10.1.6.1.1 United States Blood Plasma Derivatives Market by Type
10.1.6.1.2 United States Blood Plasma Derivatives Market by Application
10.1.6.1.3 United States Blood Plasma Derivatives Market by End User
10.1.6.2 Canada Blood Plasma Derivatives Market
10.1.6.2.1 Canada Blood Plasma Derivatives Market by Type
10.1.6.2.2 Canada Blood Plasma Derivatives Market by Application
10.1.6.2.3 Canada Blood Plasma Derivatives Market by End User
10.1.6.3 Mexico Blood Plasma Derivatives Market
10.1.6.3.1 Mexico Blood Plasma Derivatives Market by Type
10.1.6.3.2 Mexico Blood Plasma Derivatives Market by Application
10.1.6.3.3 Mexico Blood Plasma Derivatives Market by End User
10.2. EUROPE
10.2.1 Europe Blood Plasma Derivatives Market Overview
10.2.2 Europe Blood Plasma Derivatives Market Forecasts and Analysis
10.2.3 Europe Blood Plasma Derivatives Market Forecasts and Analysis - By Type
10.2.4 Europe Blood Plasma Derivatives Market Forecasts and Analysis - By Application
10.2.5 Europe Blood Plasma Derivatives Market Forecasts and Analysis - By End User
10.2.6 Europe Blood Plasma Derivatives Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Blood Plasma Derivatives Market
10.2.6.1.1 Germany Blood Plasma Derivatives Market by Type
10.2.6.1.2 Germany Blood Plasma Derivatives Market by Application
10.2.6.1.3 Germany Blood Plasma Derivatives Market by End User
10.2.6.2 France Blood Plasma Derivatives Market
10.2.6.2.1 France Blood Plasma Derivatives Market by Type
10.2.6.2.2 France Blood Plasma Derivatives Market by Application
10.2.6.2.3 France Blood Plasma Derivatives Market by End User
10.2.6.3 Italy Blood Plasma Derivatives Market
10.2.6.3.1 Italy Blood Plasma Derivatives Market by Type
10.2.6.3.2 Italy Blood Plasma Derivatives Market by Application
10.2.6.3.3 Italy Blood Plasma Derivatives Market by End User
10.2.6.4 Spain Blood Plasma Derivatives Market
10.2.6.4.1 Spain Blood Plasma Derivatives Market by Type
10.2.6.4.2 Spain Blood Plasma Derivatives Market by Application
10.2.6.4.3 Spain Blood Plasma Derivatives Market by End User
10.2.6.5 United Kingdom Blood Plasma Derivatives Market
10.2.6.5.1 United Kingdom Blood Plasma Derivatives Market by Type
10.2.6.5.2 United Kingdom Blood Plasma Derivatives Market by Application
10.2.6.5.3 United Kingdom Blood Plasma Derivatives Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Blood Plasma Derivatives Market Overview
10.3.2 Asia-Pacific Blood Plasma Derivatives Market Forecasts and Analysis
10.3.3 Asia-Pacific Blood Plasma Derivatives Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Blood Plasma Derivatives Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Blood Plasma Derivatives Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Blood Plasma Derivatives Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Blood Plasma Derivatives Market
10.3.6.1.1 Australia Blood Plasma Derivatives Market by Type
10.3.6.1.2 Australia Blood Plasma Derivatives Market by Application
10.3.6.1.3 Australia Blood Plasma Derivatives Market by End User
10.3.6.2 China Blood Plasma Derivatives Market
10.3.6.2.1 China Blood Plasma Derivatives Market by Type
10.3.6.2.2 China Blood Plasma Derivatives Market by Application
10.3.6.2.3 China Blood Plasma Derivatives Market by End User
10.3.6.3 India Blood Plasma Derivatives Market
10.3.6.3.1 India Blood Plasma Derivatives Market by Type
10.3.6.3.2 India Blood Plasma Derivatives Market by Application
10.3.6.3.3 India Blood Plasma Derivatives Market by End User
10.3.6.4 Japan Blood Plasma Derivatives Market
10.3.6.4.1 Japan Blood Plasma Derivatives Market by Type
10.3.6.4.2 Japan Blood Plasma Derivatives Market by Application
10.3.6.4.3 Japan Blood Plasma Derivatives Market by End User
10.3.6.5 South Korea Blood Plasma Derivatives Market
10.3.6.5.1 South Korea Blood Plasma Derivatives Market by Type
10.3.6.5.2 South Korea Blood Plasma Derivatives Market by Application
10.3.6.5.3 South Korea Blood Plasma Derivatives Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Blood Plasma Derivatives Market Overview
10.4.2 Middle East and Africa Blood Plasma Derivatives Market Forecasts and Analysis
10.4.3 Middle East and Africa Blood Plasma Derivatives Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Blood Plasma Derivatives Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Blood Plasma Derivatives Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Blood Plasma Derivatives Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Blood Plasma Derivatives Market
10.4.6.1.1 South Africa Blood Plasma Derivatives Market by Type
10.4.6.1.2 South Africa Blood Plasma Derivatives Market by Application
10.4.6.1.3 South Africa Blood Plasma Derivatives Market by End User
10.4.6.2 Saudi Arabia Blood Plasma Derivatives Market
10.4.6.2.1 Saudi Arabia Blood Plasma Derivatives Market by Type
10.4.6.2.2 Saudi Arabia Blood Plasma Derivatives Market by Application
10.4.6.2.3 Saudi Arabia Blood Plasma Derivatives Market by End User
10.4.6.3 U.A.E Blood Plasma Derivatives Market
10.4.6.3.1 U.A.E Blood Plasma Derivatives Market by Type
10.4.6.3.2 U.A.E Blood Plasma Derivatives Market by Application
10.4.6.3.3 U.A.E Blood Plasma Derivatives Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Blood Plasma Derivatives Market Overview
10.5.2 South and Central America Blood Plasma Derivatives Market Forecasts and Analysis
10.5.3 South and Central America Blood Plasma Derivatives Market Forecasts and Analysis - By Type
10.5.4 South and Central America Blood Plasma Derivatives Market Forecasts and Analysis - By Application
10.5.5 South and Central America Blood Plasma Derivatives Market Forecasts and Analysis - By End User
10.5.6 South and Central America Blood Plasma Derivatives Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Blood Plasma Derivatives Market
10.5.6.1.1 Brazil Blood Plasma Derivatives Market by Type
10.5.6.1.2 Brazil Blood Plasma Derivatives Market by Application
10.5.6.1.3 Brazil Blood Plasma Derivatives Market by End User
10.5.6.2 Argentina Blood Plasma Derivatives Market
10.5.6.2.1 Argentina Blood Plasma Derivatives Market by Type
10.5.6.2.2 Argentina Blood Plasma Derivatives Market by Application
10.5.6.2.3 Argentina Blood Plasma Derivatives Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BLOOD PLASMA DERIVATIVES MARKET, KEY COMPANY PROFILES
12.1. GRIFOLS, S.A.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. SK PLASMA CO., LTD.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. FUSION HEALTH CARE PVT. LTD.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BIOTEST AG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GREEN CROSS CORPORATION
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BAXTER INTERNATIONAL INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. LFB S.A.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. OCTAPHARMA AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. CSL LIMITED
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SHIRE PLC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Blood Plasma Derivatives Market - By Type
1.3.2 Blood Plasma Derivatives Market - By Application
1.3.3 Blood Plasma Derivatives Market - By End User
1.3.4 Blood Plasma Derivatives Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BLOOD PLASMA DERIVATIVES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BLOOD PLASMA DERIVATIVES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BLOOD PLASMA DERIVATIVES MARKET - GLOBAL MARKET ANALYSIS
6.1. BLOOD PLASMA DERIVATIVES - GLOBAL MARKET OVERVIEW
6.2. BLOOD PLASMA DERIVATIVES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. BLOOD PLASMA DERIVATIVES MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ALBUMIN
7.3.1. Overview
7.3.2. Albumin Market Forecast and Analysis
7.4. FACTOR VIII
7.4.1. Overview
7.4.2. Factor VIII Market Forecast and Analysis
7.5. FACTOR IX
7.5.1. Overview
7.5.2. Factor IX Market Forecast and Analysis
7.6. IMMUNOGLOBULIN
7.6.1. Overview
7.6.2. Immunoglobulin Market Forecast and Analysis
7.7. HYPERIMMUNE GLOBULIN
7.7.1. Overview
7.7.2. Hyperimmune Globulin Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. BLOOD PLASMA DERIVATIVES MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HEMOPHILIA
8.3.1. Overview
8.3.2. Hemophilia Market Forecast and Analysis
8.4. HYPOGAMMAGLOBULINEMIA
8.4.1. Overview
8.4.2. Hypogammaglobulinemia Market Forecast and Analysis
8.5. IMMUNODEFICIENCY DISEASES
8.5.1. Overview
8.5.2. Immunodeficiency Diseases Market Forecast and Analysis
8.6. VON WILLEBRANDS DISEASE (VWD)
8.6.1. Overview
8.6.2. von Willebrands Disease (vWD) Market Forecast and Analysis
8.7. OTHER APPLICATION
8.7.1. Overview
8.7.2. Other Application Market Forecast and Analysis
9. BLOOD PLASMA DERIVATIVES MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. OTHER END USERS
9.5.1. Overview
9.5.2. Other End Users Market Forecast and Analysis
10. BLOOD PLASMA DERIVATIVES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Blood Plasma Derivatives Market Overview
10.1.2 North America Blood Plasma Derivatives Market Forecasts and Analysis
10.1.3 North America Blood Plasma Derivatives Market Forecasts and Analysis - By Type
10.1.4 North America Blood Plasma Derivatives Market Forecasts and Analysis - By Application
10.1.5 North America Blood Plasma Derivatives Market Forecasts and Analysis - By End User
10.1.6 North America Blood Plasma Derivatives Market Forecasts and Analysis - By Countries
10.1.6.1 United States Blood Plasma Derivatives Market
10.1.6.1.1 United States Blood Plasma Derivatives Market by Type
10.1.6.1.2 United States Blood Plasma Derivatives Market by Application
10.1.6.1.3 United States Blood Plasma Derivatives Market by End User
10.1.6.2 Canada Blood Plasma Derivatives Market
10.1.6.2.1 Canada Blood Plasma Derivatives Market by Type
10.1.6.2.2 Canada Blood Plasma Derivatives Market by Application
10.1.6.2.3 Canada Blood Plasma Derivatives Market by End User
10.1.6.3 Mexico Blood Plasma Derivatives Market
10.1.6.3.1 Mexico Blood Plasma Derivatives Market by Type
10.1.6.3.2 Mexico Blood Plasma Derivatives Market by Application
10.1.6.3.3 Mexico Blood Plasma Derivatives Market by End User
10.2. EUROPE
10.2.1 Europe Blood Plasma Derivatives Market Overview
10.2.2 Europe Blood Plasma Derivatives Market Forecasts and Analysis
10.2.3 Europe Blood Plasma Derivatives Market Forecasts and Analysis - By Type
10.2.4 Europe Blood Plasma Derivatives Market Forecasts and Analysis - By Application
10.2.5 Europe Blood Plasma Derivatives Market Forecasts and Analysis - By End User
10.2.6 Europe Blood Plasma Derivatives Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Blood Plasma Derivatives Market
10.2.6.1.1 Germany Blood Plasma Derivatives Market by Type
10.2.6.1.2 Germany Blood Plasma Derivatives Market by Application
10.2.6.1.3 Germany Blood Plasma Derivatives Market by End User
10.2.6.2 France Blood Plasma Derivatives Market
10.2.6.2.1 France Blood Plasma Derivatives Market by Type
10.2.6.2.2 France Blood Plasma Derivatives Market by Application
10.2.6.2.3 France Blood Plasma Derivatives Market by End User
10.2.6.3 Italy Blood Plasma Derivatives Market
10.2.6.3.1 Italy Blood Plasma Derivatives Market by Type
10.2.6.3.2 Italy Blood Plasma Derivatives Market by Application
10.2.6.3.3 Italy Blood Plasma Derivatives Market by End User
10.2.6.4 Spain Blood Plasma Derivatives Market
10.2.6.4.1 Spain Blood Plasma Derivatives Market by Type
10.2.6.4.2 Spain Blood Plasma Derivatives Market by Application
10.2.6.4.3 Spain Blood Plasma Derivatives Market by End User
10.2.6.5 United Kingdom Blood Plasma Derivatives Market
10.2.6.5.1 United Kingdom Blood Plasma Derivatives Market by Type
10.2.6.5.2 United Kingdom Blood Plasma Derivatives Market by Application
10.2.6.5.3 United Kingdom Blood Plasma Derivatives Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Blood Plasma Derivatives Market Overview
10.3.2 Asia-Pacific Blood Plasma Derivatives Market Forecasts and Analysis
10.3.3 Asia-Pacific Blood Plasma Derivatives Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Blood Plasma Derivatives Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Blood Plasma Derivatives Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Blood Plasma Derivatives Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Blood Plasma Derivatives Market
10.3.6.1.1 Australia Blood Plasma Derivatives Market by Type
10.3.6.1.2 Australia Blood Plasma Derivatives Market by Application
10.3.6.1.3 Australia Blood Plasma Derivatives Market by End User
10.3.6.2 China Blood Plasma Derivatives Market
10.3.6.2.1 China Blood Plasma Derivatives Market by Type
10.3.6.2.2 China Blood Plasma Derivatives Market by Application
10.3.6.2.3 China Blood Plasma Derivatives Market by End User
10.3.6.3 India Blood Plasma Derivatives Market
10.3.6.3.1 India Blood Plasma Derivatives Market by Type
10.3.6.3.2 India Blood Plasma Derivatives Market by Application
10.3.6.3.3 India Blood Plasma Derivatives Market by End User
10.3.6.4 Japan Blood Plasma Derivatives Market
10.3.6.4.1 Japan Blood Plasma Derivatives Market by Type
10.3.6.4.2 Japan Blood Plasma Derivatives Market by Application
10.3.6.4.3 Japan Blood Plasma Derivatives Market by End User
10.3.6.5 South Korea Blood Plasma Derivatives Market
10.3.6.5.1 South Korea Blood Plasma Derivatives Market by Type
10.3.6.5.2 South Korea Blood Plasma Derivatives Market by Application
10.3.6.5.3 South Korea Blood Plasma Derivatives Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Blood Plasma Derivatives Market Overview
10.4.2 Middle East and Africa Blood Plasma Derivatives Market Forecasts and Analysis
10.4.3 Middle East and Africa Blood Plasma Derivatives Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Blood Plasma Derivatives Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Blood Plasma Derivatives Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Blood Plasma Derivatives Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Blood Plasma Derivatives Market
10.4.6.1.1 South Africa Blood Plasma Derivatives Market by Type
10.4.6.1.2 South Africa Blood Plasma Derivatives Market by Application
10.4.6.1.3 South Africa Blood Plasma Derivatives Market by End User
10.4.6.2 Saudi Arabia Blood Plasma Derivatives Market
10.4.6.2.1 Saudi Arabia Blood Plasma Derivatives Market by Type
10.4.6.2.2 Saudi Arabia Blood Plasma Derivatives Market by Application
10.4.6.2.3 Saudi Arabia Blood Plasma Derivatives Market by End User
10.4.6.3 U.A.E Blood Plasma Derivatives Market
10.4.6.3.1 U.A.E Blood Plasma Derivatives Market by Type
10.4.6.3.2 U.A.E Blood Plasma Derivatives Market by Application
10.4.6.3.3 U.A.E Blood Plasma Derivatives Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Blood Plasma Derivatives Market Overview
10.5.2 South and Central America Blood Plasma Derivatives Market Forecasts and Analysis
10.5.3 South and Central America Blood Plasma Derivatives Market Forecasts and Analysis - By Type
10.5.4 South and Central America Blood Plasma Derivatives Market Forecasts and Analysis - By Application
10.5.5 South and Central America Blood Plasma Derivatives Market Forecasts and Analysis - By End User
10.5.6 South and Central America Blood Plasma Derivatives Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Blood Plasma Derivatives Market
10.5.6.1.1 Brazil Blood Plasma Derivatives Market by Type
10.5.6.1.2 Brazil Blood Plasma Derivatives Market by Application
10.5.6.1.3 Brazil Blood Plasma Derivatives Market by End User
10.5.6.2 Argentina Blood Plasma Derivatives Market
10.5.6.2.1 Argentina Blood Plasma Derivatives Market by Type
10.5.6.2.2 Argentina Blood Plasma Derivatives Market by Application
10.5.6.2.3 Argentina Blood Plasma Derivatives Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BLOOD PLASMA DERIVATIVES MARKET, KEY COMPANY PROFILES
12.1. GRIFOLS, S.A.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. SK PLASMA CO., LTD.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. FUSION HEALTH CARE PVT. LTD.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BIOTEST AG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GREEN CROSS CORPORATION
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BAXTER INTERNATIONAL INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. LFB S.A.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. OCTAPHARMA AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. CSL LIMITED
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SHIRE PLC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Grifols, S.A.
2. SK Plasma Co., Ltd.
3. Fusion Health Care Pvt. Ltd.
4. Biotest AG
5. Green Cross Corporation
6. Baxter International Inc.
7. LFB S.A.
8. Octapharma AG
9. CSL Limited
10. Shire Plc
1. Grifols, S.A.
2. SK Plasma Co., Ltd.
3. Fusion Health Care Pvt. Ltd.
4. Biotest AG
5. Green Cross Corporation
6. Baxter International Inc.
7. LFB S.A.
8. Octapharma AG
9. CSL Limited
10. Shire Plc